Dị ka National Medical Products Administration's ọkwa nke 103 nke 2024, mbubata, ire ere, na ojiji nke UCB Pharma SA Levetiracetam Injection Concentrate ka maliteghachiri.
Dabere na nsonaazụ nyocha nke mba ofesi na-abụghị saịtị, National Medical Products Administration (NMPA) nyere ọkwa nke 67 na Ọgọst 22, 2022, na-ekpebi ịkwụsịtụ mbubata, ire ere na ojiji nke UCB Pharma SA's Levetiracetam Injection Concentrate ...
lee nkọwa